Global Consumer Healthcare Market Research Report (2021 to 2027) - by Product, Distribution and Region -

·4 min read

DUBLIN, January 20, 2022--(BUSINESS WIRE)--The "Consumer Healthcare Market Research Report by Product, by Distribution, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to's offering.

The Global Consumer Healthcare Market size was estimated at USD 318.02 billion in 2020, is expected to reach USD 340.03 billion in 2021, and is projected to grow at a CAGR of 7.28% to reach USD 520.32 billion by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Consumer Healthcare Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Consumer Healthcare Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Consumer Healthcare Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Consumer Healthcare Market?

4. What is the competitive strategic window for opportunities in the Global Consumer Healthcare Market?

5. What are the technology trends and regulatory frameworks in the Global Consumer Healthcare Market?

6. What is the market share of the leading vendors in the Global Consumer Healthcare Market?

7. What modes and strategic moves are considered suitable for entering the Global Consumer Healthcare Market?

Market Dynamics


  • High demand for self-medication

  • Analgesics penetration rising with increasing accessibility

  • Government support to offer affordable and easy access to healthcare

  • Rising geriatric population more prone to contracting diseases


  • Inconsistent regulatory framework in different countries


  • Drastic shift from medication prescription to OTC products

  • Accelerated use of online sources

  • Growing demand for branded products and private labels


  • Prevention of overuse by the consumers

  • Drastic shift from medication prescription to OTC products

Companies Mentioned

  • Abbott Laboratories Inc.

  • American Health Corporation


  • Bayer AG

  • Bionova Lifesciences

  • Boehringer Ingelheim GmbH

  • Eli Lilly and Company

  • Endo Pharmaceuticals PLC

  • Gemini Pharmaceuticals

  • Geneva Biocare

  • GlaxoSmithKline plc

  • Glenmark Pharmaceuticals Ltd.

  • Ipsen SA

  • Jasco Group of Companies

  • Johnson & Johnson Private Ltd

  • Koninklijke DSM N.V.

  • Lonza Group Ltd.

  • Novartis AG

  • Pfizer Inc.

  • Piramal Enterprises Ltd.

  • PureTek Corporation

  • Reckitt Benckiser (RB) Group PLC

  • Reckitt Benckiser LLC.

  • ROHN HealthCar

  • Sanofi S.A.

  • Stanex Drugs & Chemicals Pvt. Ltd

  • Sterling Pharmaceutical Services LLC

  • Sun Pharmaceutical Industries Limited

  • Takeda Pharma

  • Teva Pharmaceutical Industries Ltd.

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900